# A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

> **NCT00606112** · PHASE1 · COMPLETED · sponsor: **Genaera Corporation** · enrollment: 28 (actual)

## Conditions studied

- Diabetes Mellitus
- Obesity

## Interventions

- **DRUG:** Trodusquemine (MSI-1436)

## Key facts

- **NCT ID:** NCT00606112
- **Lead sponsor:** Genaera Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2009-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2009-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00606112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00606112, "A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00606112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*